México
Reino Unido
In Mexico, the Type 2 Diabetes mellitus (DM2) is a public health problem and causes early mortality. The highest prevalence is in the elderly population, between 60 and 79 years. Adherence to the treatment and the self-monitoring of blood glucose is often poor. For patients with DM2, the self-monitoring of blood glucose is a useful tool in the management of this chronic condition because it helps to establish a profile of blood glucose levels and to know how the patient is responding to nutrition and pharmacotherapy. This project is being developed with the aim to identify the requirements of older adults with diabetes mellitus type 2 for the use of the glucometer. It will be carried out clinician interviews and individual trials with older adults who suffer this illness. This paper also aims to share a learning experience with the Human-Computer Interaction community working within the medical device industry.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados